Citation: Jt. Hickok et al., The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer, J PAIN SYMP, 22(4), 2001, pp. 843-850
Authors:
Roscoe, JA
Morrow, GR
Hickok, JT
Stern, RM
Citation: Ja. Roscoe et al., Nausea and vomiting remain a significant clinical problem: Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices, J PAIN SYMP, 20(2), 2000, pp. 113-121
Authors:
Morrow, GR
Andrews, PLR
Hickok, JT
Stern, R
Citation: Gr. Morrow et al., Vagal changes following cancer chemotherapy: Implications for the development of nausea, PSYCHOPHYSL, 37(3), 2000, pp. 378-384
Authors:
Pandya, KJ
Raubertas, RF
Flynn, PJ
Hynes, HE
Rosenbluth, RJ
Kirshner, JJ
Pierce, HI
Dragalin, V
Morrow, GR
Citation: Kj. Pandya et al., Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester cancer center community clinical oncology program study, ANN INT MED, 132(10), 2000, pp. 788-793
Authors:
Spiegel, D
Morrow, GR
Classen, C
Raubertas, R
Stott, PB
Mudaliar, N
Pierce, HI
Flynn, PJ
Heard, L
Riggs, G
Citation: D. Spiegel et al., Group psychotherapy for recently diagnosed breast cancer patients: A multicenter feasibility study, PSYCHO-ONC, 8(6), 1999, pp. 482-493
Authors:
Gralla, RJ
Osoba, D
Kris, MG
Kirkbride, P
Hesketh, PJ
Chinnery, LW
Clark-Snow, R
Gill, DP
Groshen, S
Grunberg, S
Koeller, JM
Morrow, GR
Perez, EA
Silber, JH
Pfister, DG
Citation: Rj. Gralla et al., Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines, J CL ONCOL, 17(9), 1999, pp. 2971-2994
Authors:
Morrow, GR
Hickok, JT
DuBeshter, B
Lipshultz, SE
Citation: Gr. Morrow et al., Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea, J AUTON NER, 78(1), 1999, pp. 57-63
Authors:
Hickok, JT
Roscoe, JA
Morrow, GR
Stern, RM
Yang, B
Flynn, PJ
Hynes, HE
Kirshner, JJ
Rosenbluth, RJ
Citation: Jt. Hickok et al., Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings, CANCER, 86(1), 1999, pp. 64-71